Dr. Catalina Lopez-Correa is the Vice President Sector Development and Chief Scientific Officer at Genome British Columbia. With over 18 years of international experience in genomics and precision medicine, Dr. Lopez-Correa has held leadership positions in the private and public...

Moshe serves as the quality manager of the Bedomayich-Chayi public cord blood bank in Jerusalem. In addition he serves as the director of the tissue typing laboratory of the Rabin Medical Center, Israel.Dr Israeli has a PhD in transplant immunology and has completed a post-doctoral fellowship in...

Dr. Gil Van Bokkelen is the Chairman and CEO of Athersys, Inc. (NASDAQ: ATHX), a biopharmaceutical company based in Cleveland, Ohio that was established in 1995. He has served as Chairman of the Board of Directors at Athersys since August, 2000, and as CEO since the company was formed. Since...

David Wedge, Group Leader in Cancer Genomics, University of Oxford, Big Data Institute

David is a Group Leader in Cancer Genomics at the University of Oxford, Big Data Institute, having previously worked at the Wellcome Trust Sanger Institute and Manchester University. He leads the ICGC pan-cancer working group on Evolution and Heterogeneity and is an organiser of the DREAM challenge ...

David Pearce, President, Sanford Research

David Pearce is President of Research for Sanford Health. He completed his undergraduate Bachelor of Science Degree with honors in biological sciences at Wolverhampton Polytechnic in 1986. He gained his PhD in 1990 at the University of Bath, UK, and did postdoctoral training at the University of...

Charis Ober is the Founder and Executive Director of Save The Cord Foundation, a 501(c)(3) non-profit based in the US. She is a global advocate for umbilical cord blood education, awareness, research and legislation. Mrs. Ober is a graduate of the University of Arizona and has more than 25...

Detlef Bockenhauer, Clinical Professor of Paediatric Nephrology, UCL

Detlef Böckenhauer attended medical school in Germany at the Universities of Hamburg and Lübeck. He trained in paediatrics at the Children’s Hospital Altona, Hamburg and at New York University in the USA, with subsequent training in paediatric nephrology at Yale University. He was a member of the ...

Professor Margaret Sleeboom-Faulkner, Professor in Social and Medical Anthropology, University Of Sussex

Margaret Sleeboom-Faulkner acquired her doctorate on academic nationalism in China and Japan from the Amsterdam School of Social Science Research (ASSR) at Amsterdam University in 2001. After her doctorate, her 5-year Socio-genetic Marginalization in Asia Programme (SMAP) was funded, a comparative...

Damien Bates, Chief Medical Officer, SanBio, Inc.

Dr. Bates is the Chief Medical Officer & Head of Research for SanBio, Inc. a stem cell company based in both Tokyo and Mountain View, California. Prior to his current position at SanBio, Dr. Bates has held senior executive & leadership roles in clinical development and medical affairs in...

Professor Paul Veys MBBS FRCP FRCPath FRCPCHQualified in medicine from St Bartholomew’s Hospital Medical School London UK in 1983. Haematology and Blood and Marrow Transplant training at the Royal London Hospital London (1986-1988), Royal Free Hospital School of Medicine (1989-1991), Great Ormond ...

Julia Wilson, Associate Director, Wellcome Trust Sanger Institute

I build and support the relationships that are needed to support the strategic vision of the Institute. These activities range from interactions with the scientific community, commercial entities, funders and other key stakeholders.As Associate Director I work to increase awareness of the Sanger...

Susan Greenfield, Chief Executive Officer, Neuro Bio Ltd

Susan Greenfield is a research scientist, author and broadcaster based in Oxford. She has held research fellowships in the Department of Physiology Oxford, the College de France Paris, and NYU Medical Center New York. She has since been awarded 32 Honorary Degrees from British and foreign...

Zami Aberman Chairman & CEO joined Pluristem in September 2005 and changed the Company's strategy towards cellular therapeutics. Mr. Aberman's vision to use the maternal section of the Placenta (Decidua) as a source for cell therapy, combined with Pluristem's 3D culturing...

Susan L. Solomon is Founder and Chief Executive Officer of The New York Stem Cell Foundation (NYSCF) Research Institute, the world’s leading non-profit research institute dedicated to translating cutting-edge stem cell research into clinical breakthroughs. Privately funded, NYSCF is unconstrained...

Philippa Brice, External Affairs Director, P.H.G. Foundation

Dr Philippa Brice is the External Affairs Director for the PHG Foundation, an independent policy think tank that seeks to make science work for health by supporting clinical implementation of useful biomedical and digital innovations for more efficient and effective personalised healthcare. She is...

Jane Lebkowski, President of Research and Development, Asterias Biotherapeutics

Jane Lebkowski has been actively involved in the development of cell and gene therapies since 1986 and is currently President of R&D and Chief Scientific Officer at Asterias Biotherapeutics Inc, where she is responsible for all R&D of Asterias’ products. From 1998 to 2012, Dr. Lebkowski...

New programme structure: you can explore every level of development, with in depth focus on the stages and therapies that matter most to you.

The whole value chain: join new speakers discussing their experiences at every level. Process Developers, VPs and Heads of Departments as well the C-Level suite executives that the Congress is known for.

As an industry professional we know how important networking is to advance your business.

Our dedicated networking managers work with you in the run up to the event to secure meetings in advance so you can make the most of your time out of office

Multiple interactive networking breaks as well as 2 fantastic evening drinks receptions , we provide you with the opportunities to have those vital conversations with other delegates

Co-located with the Precision Medicine World Congress and Cord Blood World Europe so that you can meet those who are important in sectors that you are looking to explore

Friendly Jublia app to organise your own meetings with the right people , directly, with no fuss.

CO-LOCATED WITH CORD BLOOD WORLD EUROPE & THE WORLD PRECISION MEDICINE CONGRESS.BRINGING TOGETHER OVER 250+ SPEAKERS ACROSS THE 3 DAYS

OFFERING THE COMMERICAL AND RESEARCH COMMUNITIES THE BEST THOUGHT LEADING CONTENT

"THE BEST IN EUROPE FOR THE CELL AND GENE THERAPY SECTOR.”

Chairman & CEO, Sistemic Limited

GET INVOLVED FOR 2017

In bringing together the key players from the stem cells, cell and gene therapy and regenerative medicine communities, this event provides an unrivalled opportunity to expose and address the current challenges facing the industry.

Download the brochure to find out exactly what's in store for next year's event.